# Cogent Biosciences, Inc. (COGT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Cogent Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/COGT/mda/fy2025/): filed 2026-02-17; accession 0001193125-26-053334 (https://www.sec.gov/Archives/edgar/data/1622229/000119312526053334/cogt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/COGT/mda/fy2024/): filed 2025-02-25; accession 0000950170-25-026115 (https://www.sec.gov/Archives/edgar/data/1622229/000095017025026115/cogt-20241231.htm)
- [FY 2023 MD&A](/company/COGT/mda/fy2023/): filed 2024-02-26; accession 0000950170-24-019770 (https://www.sec.gov/Archives/edgar/data/1622229/000095017024019770/cogt-20231231.htm)
- [FY 2022 MD&A](/company/COGT/mda/fy2022/): filed 2023-03-14; accession 0000950170-23-007729 (https://www.sec.gov/Archives/edgar/data/1622229/000095017023007729/cogt-20221231.htm)
- [FY 2021 MD&A](/company/COGT/mda/fy2021/): filed 2022-03-15; accession 0001564590-22-010238 (https://www.sec.gov/Archives/edgar/data/1622229/000156459022010238/cogt-10k_20211231.htm)

Back to /company/COGT/